HeyJaredObstet Gynecol
- Indexed articles, last 90 days
- 4
- Latest publication
- Sep 23, 2026
- Outlet visibility, for Medscape
- Top 50K sites
- Earliest in this view
- Jul 30, 2026
Latest articles
New Clinical Toolkit Aims to Help Manage Perimenopause (opens the original)
Read excerpt
A new clinical toolkit from the American College of Obstetricians and Gynecologists was designed to facilitate the management of perimenopause. This reproductive stage in women, which typically begins at a median age of 47 years but can start before 45 years, is hormonally distinct from menopause and can be challenging to manage. Unlike menopause, which is characterized by estrogen deficiency, this precursor stage involves a continuum of erratic hormonal fluctuations that produce symptoms rangin
Pregnancy Hypertensive Disorders Recur in 15% of Women (opens the original)
Read excerpt
A recent cohort study reported that about 15% of previously affected mothers had recurrent severe hypertensive disorders of pregnancy (HDP) in a subsequent gestation. The highest recurrence risk was driven by the severity and timing of HDP in the index pregnancy: More than 1 in 5 patients with an index HDP between 28 and 34 weeks’ gestation or with index HDP before 28 weeks experienced recurrent HDP, according to the study published in Obstetrics & Gynecology. As major contributors to maternal m
Medicaid Expansion May Not Curb Severe Maternal Morbidity (opens the original)
Read excerpt
The 2014 Medicaid expansion under the Affordable Care Act was not associated with a reduction in rates of severe maternal morbidity (SMM) during delivery hospitalizations. "Although further study of the effects of ACA [Affordable Care Act] implementation beyond the childbirth hospitalization are needed, additional clinical and policy interventions may be required to improve maternal health outcomes," the authors wrote. The study was led by Jean Guglielminotti, MD, PhD, Columbia University Vagelo
Lipid Profile May Affect Heart Risks of Hormone Therapy (opens the original)
Read excerpt
Postmenopausal women with elevated low-density lipoprotein (LDL) cholesterol who started conjugated equine estrogens (CEE) plus medroxyprogesterone acetate (MPA) faced increased risk for coronary heart disease (CHD), while those with normal LDL cholesterol showed no increased risk. Women already receiving treatment for hyperlipidemia at baseline experienced no additional CHD risk from hormone therapy. "Measurement of blood lipids could assist with tailoring MHT [menopausal hormone therapy] to th
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50K sites
For Medscape, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.